How to Help Your Patients Find Sinemet in Stock: A Provider's Guide

When a Parkinson's disease patient calls your office unable to fill their carbidopa/levodopa prescription, the stakes are high. Unlike many medications, carbidopa/levodopa cannot be skipped or briefly paused without clinical consequences. Motor function can decline rapidly within hours of a missed dose, and abrupt discontinuation carries the risk of neuroleptic malignant-like syndrome.

This guide equips your team with the tools and workflows to proactively support patients before they run out—and to act quickly when they do.

Step 1: Identify At-Risk Patients Before the Crisis

A proactive approach prevents emergency calls. Your highest-risk patients for shortage-related access issues include:

Patients prescribed carbidopa/levodopa extended-release (ER) formulations, which are the most supply-constrained

Patients requiring more than 8 tablets per day who may face pharmacy or insurance rejection

Patients in rural areas with fewer pharmacy options

Older patients or those with caregivers who may have difficulty navigating supply issues independently

Step 2: Prescribe for Maximum Flexibility

Several prescribing practices reduce vulnerability to supply disruptions:

Write 90-day supplies when possible. Fewer fills means fewer opportunities to encounter a stockout. Mail-order pharmacies tied to insurance plans often have better access to generics.

Write for dispense as written (DAW) when manufacturer consistency matters. Patients on stable regimens may experience motor fluctuations if switched between generic manufacturers. Noting a preferred manufacturer on the prescription can help.

Pre-authorize brand ER alternatives for shortage-vulnerable patients. Submitting prior auth paperwork for Rytary or Crexont before a supply crisis gives you and your patient a ready-made backup option.

Consider a small 'bridge supply' prescription. A short-course prescription for IR tablets alongside the patient's main ER prescription gives them something to take if the ER fills fail.

Step 3: Help Patients Navigate Pharmacy Access

Your office staff can dramatically reduce patient distress by being equipped to assist with pharmacy outreach. Tools that help:

medfinder for providers: medfinder calls pharmacies near a patient's location to check real-time inventory for a specific medication and dose. This is particularly useful for your team when a patient calls in unable to fill their prescription—your staff can submit a search rather than calling pharmacies manually.

ASHP shortage list: The ASHP maintains a public shortage database at ashp.org. Check current status before calling manufacturers directly.

Hospital system pharmacies: If you practice within a health system, the inpatient or outpatient pharmacy may be able to source stock through group purchasing contracts that retail pharmacies cannot access.

Step 4: Address the Eight-Tablet Limit Proactively

Pharmacy computer systems and PBM software frequently flag prescriptions for more than 8 carbidopa/levodopa tablets per day. Preemptively add a clinical note or prior authorization when writing prescriptions exceeding this threshold. This prevents delays at the pharmacy counter and reduces calls to your office.

Step 5: Educate Patients and Caregivers

At each visit, ensure patients and caregivers understand:

Never stop carbidopa/levodopa abruptly—call the office immediately if supply is running low

Start looking for refills 10–14 days early, not on the day they run out

Availability varies by pharmacy, manufacturer, and formulation—it may take multiple calls to find stock

A written medication schedule (dose, timing, and rationale for each dose) helps caregivers maintain consistent dosing even through supply transitions

Step 6: Monitor Vitamin B6 Status

Per the March 2026 FDA safety update, all prescribers of carbidopa/levodopa products should evaluate vitamin B6 (pyridoxine) levels before initiating therapy and periodically during treatment. Consider adding B6 monitoring to your standard PD management protocol. Supplementation may be needed for patients with confirmed deficiency.

For a full clinical overview of the shortage and formulation conversion guidance, see our companion article: Sinemet shortage: What providers need to know in 2026.